SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-002091
Filing Date
2022-01-14
Accepted
2022-01-14 13:33:20
Documents
95
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea153974-6k_chinasxt.htm   iXBRL 6-K 167546
2 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30 ea153974ex99-1_chinasxt.htm   iXBRL EX-99.1 577344
3 GRAPHIC ex99-1_001.jpg GRAPHIC 22493
  Complete submission text file 0001213900-22-002091.txt   5180842

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sxtc-20210930.xsd EX-101.SCH 81422
5 XBRL CALCULATION FILE sxtc-20210930_cal.xml EX-101.CAL 41313
6 XBRL DEFINITION FILE sxtc-20210930_def.xml EX-101.DEF 267749
7 XBRL LABEL FILE sxtc-20210930_lab.xml EX-101.LAB 497838
8 XBRL PRESENTATION FILE sxtc-20210930_pre.xml EX-101.PRE 274575
89 EXTRACTED XBRL INSTANCE DOCUMENT ea153974-6k_chinasxt_htm.xml XML 594899
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 22531404
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences